首页 | 本学科首页   官方微博 | 高级检索  
检索        

血清胃泌素释放肽前体在小细胞肺癌诊断和分期中的临床意义
引用本文:高振远,欧毅梅,张竞竞,张浩然,毕明宏.血清胃泌素释放肽前体在小细胞肺癌诊断和分期中的临床意义[J].蚌埠医学院学报,2016,41(1):35-37.
作者姓名:高振远  欧毅梅  张竞竞  张浩然  毕明宏
作者单位:蚌埠医学院第一附属医院肿瘤内科, 安徽 蚌埠 233004
基金项目:蚌埠医学院科技发展基金面上项目(bykj12B25)
摘    要:目的:探讨血清胃泌素释放肽前体(proGRP)在小细胞肺癌(SCLC)与非小细胞肺癌(NSCLC)的鉴别诊断和临床分期中的价值。方法:应用化学分析法,检测62例初诊SCLC(局限期25例,广泛期37例)、38例NSCLC患者血清proGRP水平,并与神经元特异性烯醇化酶(NSE)相对照,观察其敏感度、特异度以及与肿瘤临床分期的关系。结果:单个检测proGRP、NSE和联合检测proGRP及NSE(proGRP+NSE)诊断SCLC的敏感度分别为82.93%、64.15%和71.58%。SCLC中proGRP+NSE阳性率显著高于NSE阳性率(P<0.01),但与proGRP阳性率差异无统计学意义(P>0.05)。SCLC组患者血清proGRP和NSE水平均显著高于NSCLC组(P<0.01)。SCLC广泛期患者血清proGRP和NSE值均显著高于其局限期患者(P<0.01)。结论:proGRP作为SCLC的标志物,具有敏感度高的特点,并可反映SCLC的分期。proGRP和NSE联合检测可提高SCLC诊断的准确率。

关 键 词:肺肿瘤    胃泌素释放肽前体    神经元特异性烯醇化酶
收稿时间:2013-09-21

The clinical significance of serum progastrin releasing peptide in the diagnosis and staging of small cell lung cancer
GAO Zhen-yuan,OU Yi-mei,ZHANG Jing-jing,ZHANG Hao-ran,BI Ming-hong.The clinical significance of serum progastrin releasing peptide in the diagnosis and staging of small cell lung cancer[J].Journal of Bengbu Medical College,2016,41(1):35-37.
Authors:GAO Zhen-yuan  OU Yi-mei  ZHANG Jing-jing  ZHANG Hao-ran  BI Ming-hong
Institution:Department of Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu Anhui 233004, China
Abstract:Objective:To explore the clinical value of the levels of serum progastrin releasing peptide(proGRP)in the differential diagnosis and clinical staging of small cell lung cancer( SCLC) and non-small cell lung cancer( NSCLC) . Methods:The serum levels of proGRP in 62 patients with SCLC( including 25 cases of limited stage and 37 cases of extensive stage) and 38 patients with NSCLC were measured by chemiluminescent immunoassay,which was compared with neuron specific enolase( NSE) . The sensitivity,specificity and tumor staging in all patients were analyzed. Results:The sensitivities of the single detection of proGRP, NSE and combination detection of proGRP and NSE in diagnosing SCLC were 82. 93%, 64. 15% and 71. 58%, respectively. The positive rate of the combination detection of proGRP and NSE in diagnosing SCLC was significantly higher than that of the single detection of NSE, the difference of the positive rate between combination detection proGRP and NSE and single detection of proGRP was not statistically significant(P>0. 05). The serum levels of proGRP and NSE in patients with SCLC were obviously higher than those in NSCLC patients (P<0. 01). Among the SCLC patients,the serum levels of proGRP and NSE in extensive stage patients were significantly higher than those in limited stage patients(P <0. 01). Conclusions:The ProGRP is a tumor marker of SCLC,which is high sensitivity and specificity,and can reflect the staging. The combination detection of proGRP and NSE can improve the accurate rate of SCLC diganosis.
Keywords:lung neoplasms  progastrin releasing peptide  neuron specific enolase
本文献已被 万方数据 等数据库收录!
点击此处可从《蚌埠医学院学报》浏览原始摘要信息
点击此处可从《蚌埠医学院学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号